Lucid Diagnostics Inc. LUCD 深 滬
已收盤 04-02 16:00:00 美东时间
1.14
-0.010
-0.87%
華盛通- 最 高1.16
- 今 開1.12
- 成交量 29.90万股
- 最 低 1.12
- 昨 收 1.15
- 總市值 2.02亿
- 52周最高 1.70
- 市盈率 靜 --
- 換手率 0.17%
- 52周最低 0.9495
- 委 比 1.98%
- 總股本 1.77亿
- 歷史最高 13.52
- 量 比 0.45
- 振 幅 3.48%
- 歷史最低 0.6301
- 每 手 1
- 風險率 0.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio. Octeris, Inc. subsidiary formed to advance endoscopic esophagea...
04-02 20:01
美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
美股大行评级 | 大摩、高盛上调Denali Therapeutics目标价；Chewy、沛齐遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Atossa Therapeutics"买入"评级，目标价从7美元升至25美元；Needham：维持Nkarta"买入"评级，目标价从10美元升至11美元
03-27 10:22
Lucid Diagnostics Files Prospectus To Offer And Sell Shares Of Common Stock Of Up To $25M
-SEC Filing
03-27 05:07
Needham Reiterates Buy on Lucid Diagnostics, Maintains $3 Price Target
Needham analyst Mike Matson reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $3 price target.
03-27 00:28
Lucid Diagnostics FY2025 net loss widens to $58 million; revenue rises 8.28% to $4.7 million
Lucid Diagnostics FY2025 net loss widens to $58 million; revenue rises 8.28% to $4.7 million Lucid published a Form 8-K reporting fourth-quarter and full-year 2025 results, including 4Q revenue of USD 1.5 million, up 25.65%. Operating expenses in 4Q were USD 15.5 million, up 14.32%. GAAP net loss at
03-26 20:02
Lucid Diagnostics Q4 Adj. EPS $(0.10), Inline, Sales $1.504M Beat $1.379M Estimate
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 47.37 percent increase over losses of $(0.19) per share from the same period last year.
03-26 20:01
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
Lucid Diagnostics schedules fourth-quarter and full-year 2025 business update call and webcast
Lucid Diagnostics schedules fourth-quarter and full-year 2025 business update call and webcast Lucid Diagnostics will hold a fourth quarter and full year 2025 business update conference call and webcast on March 26, 2026, at 8:30 AM ET. The webcast will be available at luciddx.com . Lishan Aklog wil
03-12 21:10
What's Going On With PAVmed Shares Thursday?
PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contract
01-22 22:23
